Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag with or without HMA in MDS after HMA failure
NCT01893372Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2013
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in myelodysplastic syndrome (MDS), sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2013; status: completed.
02
Drugs
eltrombopag
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01893372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01893372.